Betahistine Dihydrochloride (betahistine hydrochloride) contains not less than 99.0% and not more than 101.0% of C8H12H2‧2HCl, calculated on the dried basis.

申請商
鴻傑藥品有限公司 
適應症
治療梅尼艾氏症候群所引起之眩暈、聽力障礙。
含量
0